AZO three-lens brief
Evidence-based stock research on AZO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 5% of its 52-week range — deep in the lower band.
- Trading at 5% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $3969.38 — 32% above current (24 analysts).
AZO closed at $3006.45 (-0.13%) as of 2026-07-10. Market cap: $49.08B. P/E (trailing) 20.7. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $3969.38 — 32% above current (24 analysts).. Concerns: trading at 5% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $4.84B, net income $641.49M, free cash flow $903.78M.
Why three lenses on AZO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AZOacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AZO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AZO brief"></iframe>